Impact and Repercussion of the SARS-CoV-2 Pandemic in the Assisted Reproduction Units in Spain
DOI:
https://doi.org/10.31907/2309-4400.2020.08.08Keywords:
Impact, Repercussion, SARS, Pandemic, Reproduction.Abstract
During the months of March, April and May of 2020 the Spanish Assisted Reproduction Units had to stop their assistance activity due to the health situation caused by the COVID-19 pandemic. Its reactivation has required a substantial modification in the way of working in them, changing the assistance routines and designing protocols that guarantee, as much as possible, the security of patients and staff of the centers devoted to reproductive medicine. It is analyzed the medical and biological arguments that have been assessed in order to advise the reopening of the Assisted Reproduction Units within the current context of the pandemic in Spain and the European Union.
References
Instituto Nacional de Estadística español.( INE) www.ine.es
Registro de Actividad de la Sociedad Española de Fertilidad ( SEF) 2017 www.registrosef.com
Boeltín Oficial del Estado 1-4 C.2 5.2 ( BOE ) published document on 04-01-2020 www.boe.es
Ministerio de Sanidad ,Consumo y Bienestar Social español. ( MSCBS ) www.mscbs.go.es
Equipo COVID-19 CNE CMN ( ISCIII ) www.recomendacionmedica.com
Sociedad Española de Obstetricia y Ginecología , Sección de Esterilidad e Infertilidad ( SEGO-SEISEGO) published document on 04-15-2020 www.sego.es
Asociación para el Estudio de la Biología de la Reproducción y Sociedad Española de Fertilidad ( ASEBIR-SEF) published document on 04-20-2020 www. asebir.com www.serfertilidad.net
European Society of Human Reproduction and Embriogy ( ESHRE ) published document on 04-23-2020 www.esrhe.eu
Buenas Prácticas en los Centros de Trabajo. MinisteriodeSanidad;2020www.lamoncloa.gob.es/servicios deprensa/presidencia/Documents/2020/GUIACENTROST RABAJOCOVID19b.pdf
The Revised Guidelines for good practice in IVF laboratories (2015).ESHRE www.eshre.eu/Guidelines-andLegal/Guidelines/Revised-guidelines-for-good-practice-inIVF-laboratories-(2015).aspx
Manual de Bioseguridad en el Laboratorio. Organización Mundial de la Salud;2005.Ginebra. ( OMS/WHO ) www.who.int/topics/medical_waste/manual_bioseguridad_l aboratorio.pdf
Zaigham M, Andersson O. Maternal and Perinatal Outcomes with COVID-19: a systematic review of 108 pregnancies. Acta Obstet Gynecol Scand published document on 04/09/2020www.obgyn.onlinelibrary.wiley.com/doi/abs/10.1 111/aogs.13867
Chen h, Guo J, Wang C, Luo F, Yu X, Zhang W, et al. Clinical characteristics and intrauterine vertical transmission potencial of COVID-19 infection in nine pregnant woman: a retrospective review of medical records. Lancet Lond Engl.07 de 2020;395 ( 10226 ):809-15
Zhu H, Wang L, Fang C, Peng S, Zhang W, et al. Clinical analysis of 10 neonates born to mothers with 2019-nCoV pneumonia. Transl Pediatr. February 2020;9 (1):51-60
Manejo de la mujer embarazada y el recién nacido con COVID-19 published document on 03/17/2020 www.mscbs.gob.es/profesionales/saludPublica/ccayes/alert asActual/nCovChina/documentos/Documento_manejo_em barazo_recien_nacido.pdf
Sociedad Española de Inmunología ( SEI ) published document on 04-02-2020 www.inmunologia.org versión v 01
Yan et al. Structural basis for recognition of SARS.CoV-2 by full-length human ACE2 Science. www.doi.org/10.1126/science-abb 2762
Comunicado OMS/WHO published document on 03- 30.2020 www.who.int
